The hnRNPM contains three RNA recognition structural domains that regulate RNA alternative splicing and has recently been shown to induce EMT in cancer and contribute to the maintenance of the mesenchymal phenotype [44,45]. The gene discussed is HNRNPM; the disease is cancer.